PMC:7536919
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 163-167 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T2 | 285-294 | Body_part | denotes | (NK) cell | http://purl.org/sig/ont/fma/fma63147 |
| T3 | 290-294 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T4 | 1024-1032 | Body_part | denotes | NK cells | http://purl.org/sig/ont/fma/fma63147 |
| T5 | 1027-1032 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T6 | 1110-1120 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
| T7 | 1121-1125 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 40-48 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 232-240 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 344-352 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 433-440 | Disease | denotes | COVID19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 535-542 | Disease | denotes | COVID19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 1194-1202 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 142-145 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
| T2 | 147-150 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
| T3 | 161-167 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
| T4 | 285-294 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | (NK) cell |
| T5 | 304-305 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T6 | 328-330 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T7 | 415-416 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 518-519 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 711-712 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T10 | 796-797 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T11 | 858-859 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T12 | 1024-1032 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cells |
| T13 | 1068-1069 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T14 | 1121-1125 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 391-396 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T2 | 1137-1139 | Chemical | denotes | KL | http://purl.obolibrary.org/obo/CHEBI_74561 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 976-999 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immune responses |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-57 | Sentence | denotes | Peripheral biomarkers’ panel for severe COVID‐19 patients |
| T2 | 58-77 | Sentence | denotes | D'ALESSANDRO et al. |
| T3 | 79-87 | Sentence | denotes | Abstract |
| T4 | 88-96 | Sentence | denotes | Abstract |
| T5 | 97-241 | Sentence | denotes | It is widely reported in the literature that CD4, CD8 and total T cell count are significantly reduced in critically ill patients with COVID‐19. |
| T6 | 242-362 | Sentence | denotes | Few weeks ago, we suggested natural killer (NK) cell count as a marker of severity in 34 hospitalized COVID‐19 patients. |
| T7 | 363-481 | Sentence | denotes | On this topic, our research group firstly described a novel potential COVID19 severity marker, Krebs von den Lungen‐6. |
| T8 | 482-622 | Sentence | denotes | This study aimed to investigate how a combination of COVID19 severity markers could be helpful in the clinical management of these patients. |
| T9 | 623-894 | Sentence | denotes | The combination of these validated, reproducible and non‐expensive bioindicators showed a good accuracy in discriminating between severe and non‐severe patients, suggesting a promising value of this approach in the early prediction of a more aggressive disease phenotype. |
| T10 | 895-1212 | Sentence | denotes | Despite its monocentric design, our study confirms the reliable dysregulation of innate immune responses, particularly involving NK cells, and suggests that surveillance of a peripheral biomarkers’ panel, including lymphocyte cell counts and KL‐6, may be useful in the clinical management of severe COVID‐19 patients. |
| T11 | 1213-1252 | Sentence | denotes | This article is protected by copyright. |
| T12 | 1253-1273 | Sentence | denotes | All rights reserved. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1 | 40-48 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 18 | 142-145 | Gene | denotes | CD4 | Gene:920 |
| 19 | 147-150 | Gene | denotes | CD8 | Gene:925 |
| 20 | 458-480 | Gene | denotes | Krebs von den Lungen‐6 | Gene:4582 |
| 21 | 1137-1141 | Gene | denotes | KL‐6 | Gene:4582 |
| 22 | 218-226 | Species | denotes | patients | Tax:9606 |
| 23 | 353-361 | Species | denotes | patients | Tax:9606 |
| 24 | 613-621 | Species | denotes | patients | Tax:9606 |
| 25 | 775-783 | Species | denotes | patients | Tax:9606 |
| 26 | 1203-1211 | Species | denotes | patients | Tax:9606 |
| 27 | 203-217 | Disease | denotes | critically ill | MESH:D016638 |
| 28 | 232-240 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 29 | 344-352 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 30 | 433-440 | Disease | denotes | COVID19 | MESH:C000657245 |
| 31 | 535-542 | Disease | denotes | COVID19 | MESH:C000657245 |
| 32 | 865-883 | Disease | denotes | aggressive disease | MESH:D001523 |
| 33 | 1194-1202 | Disease | denotes | COVID‐19 | MESH:C000657245 |